Trexquant Investment LP Sells 60,964 Shares of Enhabit, Inc. (NYSE:EHAB)

Trexquant Investment LP reduced its position in Enhabit, Inc. (NYSE:EHAB - Free Report) by 29.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 142,695 shares of the company's stock after selling 60,964 shares during the period. Trexquant Investment LP owned about 0.28% of Enhabit worth $1,114,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. FMR LLC grew its holdings in shares of Enhabit by 138.4% during the third quarter. FMR LLC now owns 3,388 shares of the company's stock valued at $27,000 after buying an additional 1,967 shares in the last quarter. Quantbot Technologies LP acquired a new stake in shares of Enhabit during the 4th quarter valued at $45,000. Corient Private Wealth LLC purchased a new position in shares of Enhabit during the 4th quarter valued at $79,000. Stoneridge Investment Partners LLC increased its stake in shares of Enhabit by 22.6% in the fourth quarter. Stoneridge Investment Partners LLC now owns 12,533 shares of the company's stock worth $98,000 after acquiring an additional 2,308 shares during the last quarter. Finally, Zacks Investment Management acquired a new stake in shares of Enhabit during the 3rd quarter valued at about $107,000.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group restated a "buy" rating on shares of Enhabit in a report on Thursday, March 6th.

Remove Ads

Enhabit Stock Performance

Shares of NYSE EHAB traded up $0.11 during mid-day trading on Tuesday, hitting $7.90. The company had a trading volume of 103,167 shares, compared to its average volume of 482,711. Enhabit, Inc. has a 12 month low of $6.85 and a 12 month high of $10.70. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46. The firm has a market cap of $398.79 million, a P/E ratio of -3.41 and a beta of 1.60. The business's 50-day simple moving average is $8.47 and its 200-day simple moving average is $7.99.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.